← FDA Drug Approvals (Drugs@FDA)
OPIPZA
NDA · New Drug Application · Sponsor: XIAMEN LP PHARM CO · Approved 2024-07-22
Drug application
- FDA Application #
NDA216655- Application type
- New Drug Application
- Brand name
- OPIPZA
- Generic name
- ARIPIPRAZOLE
- Active ingredients
- ARIPIPRAZOLE
- Dosage form
- FILM
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- XIAMEN LP PHARM CO
- Manufacturer
- Carwin Pharmaceutical Associates, LLC
- First approval
- 2024-07-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown